Novavax
NVAX
#5737
Rank
A$1.90 B
Marketcap
A$11.57
Share price
-3.02%
Change (1 day)
14.65%
Change (1 year)

EPS for Novavax (NVAX)

EPS in 2026 (TTM): A-$2.28

According to Novavax's latest financial reports the company's current EPS (TTM) is A-$2.28. In 2025 the company made an earnings per share (EPS) of A$4.11 an increase over its 2024 EPS that were of A-$1.84.

EPS history for Novavax from 2014 to 2026

Annual EPS

Year EPS Change
2026 (TTM)A-$2.28-155.42%
2025A$4.11-322.76%
2024A-$1.84
2022A-$12.44-64.36%
2021A-$34.91243%
2020A-$10.1819.75%
2019A-$8.50-43.86%
2018A-$15.14-19.84%
2017A-$18.89-38.83%
2016A-$30.8874.58%
2015A-$17.6963.89%
2014A-$10.79

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Novartis
NVS
A$7.87-445.39%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
A$1.06-146.71%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
A$10.67-568.42%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
A$4.31-289.30%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sarepta Therapeutics
SRPT
A-$3.94 73.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
A-$6.52 186.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
A$3.03-232.89%๐Ÿ‡บ๐Ÿ‡ธ USA
NanoViricides
NNVC
A-$0.66-71.05%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
A-$2.02-11.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
A-$7.55 231.58%๐Ÿ‡บ๐Ÿ‡ธ USA